Adopting intensive lifestyle changes can slow or stop progression of early-stage Alzheimer’s disease, according to a new study.

The disease has been diagnosed in more than 100 former NFL players and arisen as an existential threat to the United States’ ...

Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach ...

Summary: Women are nearly twice as likely as men to develop Alzheimer’s disease, a disparity that can’t be fully explained by longevity alone. Researchers are exploring biological differences, ...

While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing. Understanding the difference isn’t just helpful for clarity, it’s ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long associated with Alzheimer's disease helps lung cancer spread to the ...

Tau protein in Alzheimer's disease Alzheimer’s Disease (AD) is the most prevalent neurodegenerative disorder among the elderly, marked by abnormal Tau phosphorylation.

Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder marked primarily by β-amyloid (Aβ) deposition and abnormal Tau protein phosphorylation. Recently, brain organoids have ...

Researchers have developed a blood test that detects Alzheimer's biomarkers at single-molecule levels, enabling earlier, non-invasive diagnosis using extracellular vesicles.

This week's topics include using CT to help determine brain death, PET scanning for tau in Alzheimer's, screen time trajectories in U.S. youth and mental health, and cannabis and your heart.